Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates Book Section
| Authors: | Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Clark, B.; Stubblefield, M.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L. |
| Editors: | Skinner, M.; Berk, J. L.; Connors, L. H.; Seldin, D. C. |
| Article/Chapter Title: | Risk-adapted melphalan with stem cell transplant (SCT) and adjuvant dexamethasone (dex) +/- thalidomide (thal) achieves low treatment related mortality and high hematologic response rates |
| Keywords: | long-term survival; hematologic response; complete remission; treatment-related mortality; organ response rate |
| Book Title: | XIth International Symposium on Amyloidosis |
| ISBN: | 978-1-4200-4281-8 |
| Publisher: | CRC Press/Taylor & Francis Group |
| Publication Place: | Boca Raton, FL |
| Date Published: | 2008-01-01 |
| Start Page: | 234 |
| End Page: | 236 |
| Language: | English |
| ACCESSION: | BIOSIS:PREV200800070657 |
| PROVIDER: | biosis |
| DOI: | 10.1201/9781420043358.ch78 |
| Notes: | --- - Book Chapter: 78; Meeting - 11th International Symposium on Amyloidosis - Woods Hole, MA, USA - November 05 -09, 2006 - 6000 broken sound parkway nw, ste 300, boca raton, fl 33487-2742 usa - "Source: Biosis" |
Altmetric
Citation Impact
BMJ Impact Analytics
